Dataminr Stock Price, Valuation & IPO
Private company — Dataminr is privately held. Its shares are not listed on any public exchange and can only be accessed through private secondary transactions.
Status source: AXEVIL investment team
$7.72 per share (AXEVIL consensus estimate)
Source: AXEVIL consensus of recent secondary transactions · as of 27 October 2026
Last round valuation: $4.1B
Source: F, March 2021, post-money
Total raised: ~$1.5B
Data last updated: 27 October 2026
About Dataminr
AI platform for real-time event detection from public sources (news, social media, sensors): corporate risk, physical security, defense applications. Clients include Fortune 500 companies, the US government, and NATO.
Dataminr pulls the first signals of incidents, attacks, and crises out of a million public sources in real time and gets them to security teams ahead of the news. Founded in 2009 in New York. The platform processes public data streams and separates from the noise the events that matter to a specific customer — from emergencies to cyber incidents. The business has changed qualitatively since its last valuation: a cyber-defense line launched on March 23, 2026, and ThreatConnect was acquired with more than 250 enterprise customers; recurring revenue is roughly $200M. Last valued at $4.1B in a Series F (March 2021); roughly $1.5B raised.
- Sector: AI / Enterprise
- Headquarters: New York, NY
- Founded: 2009
Key highlights
- The valuation has not been revised in five years while the business doubled. The $4.1B mark was set in March 2021, when there was no cyber-defense line, no ThreatConnect with its 250+ enterprise customers, and no recurring revenue of roughly $200M.
- IPO preparation has begun and is publicly visible. In June 2025 Tiffany Buchanan of CrowdStrike became CFO, having spent thirteen years there running finance and capital markets and gone the full path from Series A to listing.
- A second market is open and already bringing in contracts. The cyber-defense line launched on March 23, 2026 and is sold to the same base that has already bought Pulse.
- Sales channels were plugged in during 2026. The June 9, 2026 partnership with TD SYNNEX opens access to 35,000+ resellers in North America, and the March agreement with Arrow Electronics opens the Europe, Middle East, and Africa market.
Funding rounds
| Date | Round | Price / share | Post-money valuation |
|---|---|---|---|
| 23 March 2021 | F | $44.00 | $4.1B |
| 29 June 2018 | E | $19.90 | $1.6B |
| 17 March 2015 | D | $12.75 | $704M |
| 8 August 2013 | C | $3.65 | $157M |
Frequently asked questions
How can I buy Dataminr stock before the IPO?
Not on a public exchange — Dataminr is privately held. Shares change hands only in private secondary transactions. AXEVIL structures those as dedicated US special purpose vehicles for accredited investors, subject to availability and to the rules of your jurisdiction.
What is the Dataminr stock price?
A private company has no single official share price. AXEVIL's consensus estimate is $7.72 per share as of 27 October 2026. Its most recent round implied a post-money valuation of $4.1B (March 2021).
What is Dataminr's valuation (net worth)?
Dataminr's most recent funding round valued the company at $4.1B post-money (March 2021) — the latest primary-market measure of what the company is worth. Secondary trades can price its shares above or below that round.
When will Dataminr IPO?
No listing has been announced. AXEVIL does not forecast IPO dates — this page states what has actually been filed or reported, with the date it was last checked.
Is Dataminr publicly traded?
No. Dataminr is a private company and its shares are not listed on any public exchange.
Does Dataminr have a stock symbol?
No. Dataminr has no ticker symbol because its shares are not listed on any exchange; a symbol is assigned only at an IPO or direct listing.
Similar companies
- DataRobot — AI / Enterprise
- Automation Anywhere — AI / Enterprise
- Decagon — AI / Enterprise
- The Bot Company — Robotics
- KoBold Metals — Industrials
- Chai Discovery — Healthcare & Biotech
Risk disclosure
Nothing on this page is an offer to sell or a solicitation to buy any security, and it is not investment advice. Valuations and share prices shown here are AXEVIL estimates built from primary sources — filings, announced rounds and completed secondary transactions — not quoted market prices, and they can be revised. Private-company shares are illiquid, may be impossible to sell, and the entire amount invested can be lost. Availability depends on your jurisdiction and on accredited-investor status.